A citation-based method for searching scientific literature

Mourad Ouzzani, Hossam Hammady, Zbys Fedorowicz, Ahmed Elmagarmid. Syst Rev 2016
Times Cited: 2282







List of co-cited articles
61 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.
David Moher, Alessandro Liberati, Jennifer Tetzlaff, Douglas G Altman. PLoS Med 2009
26

RoB 2: a revised tool for assessing risk of bias in randomised trials.
Jonathan A C Sterne, Jelena Savović, Matthew J Page, Roy G Elbers, Natalie S Blencowe, Isabelle Boutron, Christopher J Cates, Hung-Yuan Cheng, Mark S Corbett, Sandra M Eldridge,[...]. BMJ 2019
8

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.
David Moher, Alessandro Liberati, Jennifer Tetzlaff, Douglas G Altman. BMJ 2009
8

Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement.
David Moher, Larissa Shamseer, Mike Clarke, Davina Ghersi, Alessandro Liberati, Mark Petticrew, Paul Shekelle, Lesley A Stewart. Syst Rev 2015
8

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration.
Alessandro Liberati, Douglas G Altman, Jennifer Tetzlaff, Cynthia Mulrow, Peter C Gøtzsche, John P A Ioannidis, Mike Clarke, P J Devereaux, Jos Kleijnen, David Moher. PLoS Med 2009
7

The Cochrane Collaboration's tool for assessing risk of bias in randomised trials.
Julian P T Higgins, Douglas G Altman, Peter C Gøtzsche, Peter Jüni, David Moher, Andrew D Oxman, Jelena Savovic, Kenneth F Schulz, Laura Weeks, Jonathan A C Sterne. BMJ 2011
7

PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation.
Andrea C Tricco, Erin Lillie, Wasifa Zarin, Kelly K O'Brien, Heather Colquhoun, Danielle Levac, David Moher, Micah D J Peters, Tanya Horsley, Laura Weeks,[...]. Ann Intern Med 2018
7

Bias in meta-analysis detected by a simple, graphical test.
M Egger, G Davey Smith, M Schneider, C Minder. BMJ 1997
7

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.
David Moher, Alessandro Liberati, Jennifer Tetzlaff, Douglas G Altman. Ann Intern Med 2009
7

ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions.
Jonathan Ac Sterne, Miguel A Hernán, Barnaby C Reeves, Jelena Savović, Nancy D Berkman, Meera Viswanathan, David Henry, Douglas G Altman, Mohammed T Ansari, Isabelle Boutron,[...]. BMJ 2016
7

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration.
Alessandro Liberati, Douglas G Altman, Jennifer Tetzlaff, Cynthia Mulrow, Peter C Gøtzsche, John P A Ioannidis, Mike Clarke, P J Devereaux, Jos Kleijnen, David Moher. BMJ 2009
6

QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies.
Penny F Whiting, Anne W S Rutjes, Marie E Westwood, Susan Mallett, Jonathan J Deeks, Johannes B Reitsma, Mariska M G Leeflang, Jonathan A C Sterne, Patrick M M Bossuyt. Ann Intern Med 2011
6

Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews.
Beverley J Shea, Jeremy M Grimshaw, George A Wells, Maarten Boers, Neil Andersson, Candyce Hamel, Ashley C Porter, Peter Tugwell, David Moher, Lex M Bouter. BMC Med Res Methodol 2007
5

GRADE: an emerging consensus on rating quality of evidence and strength of recommendations.
Gordon H Guyatt, Andrew D Oxman, Gunn E Vist, Regina Kunz, Yngve Falck-Ytter, Pablo Alonso-Coello, Holger J Schünemann. BMJ 2008
5

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.
David Moher, Alessandro Liberati, Jennifer Tetzlaff, Douglas G Altman. Int J Surg 2010
4

Assessing bias in studies of prognostic factors.
Jill A Hayden, Danielle A van der Windt, Jennifer L Cartwright, Pierre Côté, Claire Bombardier. Ann Intern Med 2013
4

Development of a critical appraisal tool to assess the quality of cross-sectional studies (AXIS).
Martin J Downes, Marnie L Brennan, Hywel C Williams, Rachel S Dean. BMJ Open 2016
405
4


The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration.
Alessandro Liberati, Douglas G Altman, Jennifer Tetzlaff, Cynthia Mulrow, Peter C Gøtzsche, John P A Ioannidis, Mike Clarke, P J Devereaux, Jos Kleijnen, David Moher. J Clin Epidemiol 2009
3


Measuring inconsistency in meta-analyses.
Julian P T Higgins, Simon G Thompson, Jonathan J Deeks, Douglas G Altman. BMJ 2003
3

Evaluation of the quality of prognosis studies in systematic reviews.
Jill A Hayden, Pierre Côté, Claire Bombardier. Ann Intern Med 2006
973
3

Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation.
Larissa Shamseer, David Moher, Mike Clarke, Davina Ghersi, Alessandro Liberati, Mark Petticrew, Paul Shekelle, Lesley A Stewart. BMJ 2015
3

Quantifying heterogeneity in a meta-analysis.
Julian P T Higgins, Simon G Thompson. Stat Med 2002
3


Intimate Partner Violence Among Mothers of Sick Newborns in Ghana.
Kathryn Spangenberg, Priscilla Wobil, Cassandra L Betts, Theodore F Wiesner, Katherine J Gold. Health Care Women Int 2016
8
25

Systematic review or scoping review? Guidance for authors when choosing between a systematic or scoping review approach.
Zachary Munn, Micah D J Peters, Cindy Stern, Catalin Tufanaru, Alexa McArthur, Edoardo Aromataris. BMC Med Res Methodol 2018
949
2

[Familial incidence of renal malformations].
J Chmielewski, L Janusz, Stasikiewicz-Chmielewska, D Gazdowska-Nawrocka. Wiad Lek 1971
8
25

Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide.
Tammy C Hoffmann, Paul P Glasziou, Isabelle Boutron, Ruairidh Milne, Rafael Perera, David Moher, Douglas G Altman, Virginia Barbour, Helen Macdonald, Marie Johnston,[...]. BMJ 2014
2

GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables.
Gordon Guyatt, Andrew D Oxman, Elie A Akl, Regina Kunz, Gunn Vist, Jan Brozek, Susan Norris, Yngve Falck-Ytter, Paul Glasziou, Hans DeBeer,[...]. J Clin Epidemiol 2011
2


Clinical Value of CYP2C19 Genetic Testing for Guiding the Antiplatelet Therapy in a Chinese Population.
De-Liang Shen, Bo Wang, Jing Bai, Qing Han, Chuang Liu, Xiao-Hui Huang, Jin-Ying Zhang. J Cardiovasc Pharmacol 2016
43
4

Assessing the quality of reports of randomized clinical trials: is blinding necessary?
A R Jadad, R A Moore, D Carroll, C Jenkinson, D J Reynolds, D J Gavaghan, H J McQuay. Control Clin Trials 1996
2


Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium.
Roxana Mehran, Sunil V Rao, Deepak L Bhatt, C Michael Gibson, Adriano Caixeta, John Eikelboom, Sanjay Kaul, Stephen D Wiviott, Venu Menon, Eugenia Nikolsky,[...]. Circulation 2011
2

mHealth Supportive Care Intervention for Parents of Children With Acute Lymphoblastic Leukemia: Quasi-Experimental Pre- and Postdesign Study.
Jingting Wang, Doris Howell, Nanping Shen, Zhaohui Geng, Fulei Wu, Min Shen, Xiaoyan Zhang, Anwei Xie, Lin Wang, Changrong Yuan. JMIR Mhealth Uhealth 2018
11
18

Detecting dementia with the mini-mental state examination in highly educated individuals.
Sid E O'Bryant, Joy D Humphreys, Glenn E Smith, Robert J Ivnik, Neill R Graff-Radford, Ronald C Petersen, John A Lucas. Arch Neurol 2008
388
2

Scoping studies: advancing the methodology.
Danielle Levac, Heather Colquhoun, Kelly K O'Brien. Implement Sci 2010
2

Synthesis without meta-analysis (SWiM) in systematic reviews: reporting guideline.
Mhairi Campbell, Joanne E McKenzie, Amanda Sowden, Srinivasa Vittal Katikireddi, Sue E Brennan, Simon Ellis, Jamie Hartmann-Boyce, Rebecca Ryan, Sasha Shepperd, James Thomas,[...]. BMJ 2020
312
2

Utilization of the PICO framework to improve searching PubMed for clinical questions.
Connie Schardt, Martha B Adams, Thomas Owens, Sheri Keitz, Paul Fontelo. BMC Med Inform Decis Mak 2007
731
2

Prevalence of chronic low back pain: systematic review.
Rodrigo Dalke Meucci, Anaclaudia Gastal Fassa, Neice Muller Xavier Faria. Rev Saude Publica 2015
251
2


Assessing intrarater, interrater and test-retest reliability of continuous measurements.
Valentin Rousson, Theo Gasser, Burkhardt Seifert. Stat Med 2002
239
2

Does physical activity attenuate, or even eliminate, the detrimental association of sitting time with mortality? A harmonised meta-analysis of data from more than 1 million men and women.
Ulf Ekelund, Jostein Steene-Johannessen, Wendy J Brown, Morten Wang Fagerland, Neville Owen, Kenneth E Powell, Adrian Bauman, I-Min Lee. Lancet 2016
2

Prevalence of obstructive sleep apnea in the general population: A systematic review.
Chamara V Senaratna, Jennifer L Perret, Caroline J Lodge, Adrian J Lowe, Brittany E Campbell, Melanie C Matheson, Garun S Hamilton, Shyamali C Dharmage. Sleep Med Rev 2017
585
2

GRADE guidelines: 4. Rating the quality of evidence--study limitations (risk of bias).
Gordon H Guyatt, Andrew D Oxman, Gunn Vist, Regina Kunz, Jan Brozek, Pablo Alonso-Coello, Victor Montori, Elie A Akl, Ben Djulbegovic, Yngve Falck-Ytter,[...]. J Clin Epidemiol 2011
2


Use of GRADE for assessment of evidence about prognosis: rating confidence in estimates of event rates in broad categories of patients.
Alfonso Iorio, Frederick A Spencer, Maicon Falavigna, Carolina Alba, Eddie Lang, Bernard Burnand, Tom McGinn, Jill Hayden, Katrina Williams, Beverly Shea,[...]. BMJ 2015
241
2

AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both.
Beverley J Shea, Barnaby C Reeves, George Wells, Micere Thuku, Candyce Hamel, Julian Moran, David Moher, Peter Tugwell, Vivian Welch, Elizabeth Kristjansson,[...]. BMJ 2017
2



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.